Therapeutic potential of

studies have demonstrated that statins, in addition to their lipid-lowering effects, have anti-inflam-matory and immunomodulatory properties [1]. These properties of statins have suggested that they could have beneficial effects in immune mediated neurological disorders [2, 3]. In particular, lovastatin has been shown to in-hibit the induction of inducible nitric oxide synthase and proin-flammatory cytokines in rat astro-cytes, microglia and macrophages [2] and to repress MHC-II medi